Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

Ambien, Zolpidem Newswire

Comprehensive Real-Time News Feed for Ambien, Zolpidem (generic).

Results 1 - 20 of 591 in Ambien, Zolpidem (generic)

  1. Sleep treatment: How neurofeedback holds promise for insomnia sufferersRead the original story

    Friday May 17 | Examiner.com

    Upwards of 70 million Americans suffer from the debilitating effects of insomnia and other sleep disorders.

    Comment?

  2. Closer Look: Scary Side Effect of AmbienRead the original story

    Thursday May 23 | 13WHAM

    "I just couldn't sleep and I had terrible insomnia, I tried all the natural remedies that people suggest -- the melatonin -- and nothing was working,"Heather Saffer said.

    Comment?

  3. Merck's insomnia drug moves a step closer to FDA approvalRead the original story

    Thursday May 23 | Fox News

    Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses.

    Comment?

  4. Merck Insomnia Drug Is Safe Only in Lower Doses, FDA Panel SaysRead the original story

    Thursday May 23 | The Washington Post

    Merck & Co.'s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi's Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said.

    Comment?

  5. In Drug News... Labeling changes for zolpidem tartrate productsRead the original story

    Thursday May 23 | Nursing Center

    No need to go searching all over for the latest information on new drugs, indications, medication errors and more.

    Comment?

  6. Merck's insomnia drug moves a step closer to U.S. approvalRead the original story w/Photo

    Wednesday May 22 | Reuters

    Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses.

    Comment?

  7. Experts favor US approval of Merck sleeping pillRead the original story

    Wednesday May 22 | PhysOrg Weblog

    An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

    Comment?

  8. FDA has safety concerns with Merck insomnia drugRead the original story

    Tuesday May 21 | Lincoln Daily News

    Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking. 1 comment

  9. FDA raises concerns about experimental sleep aid suvorexantRead the original story w/Photo

    Monday May 20 | CBS News

    While an experimental insomnia drug from Merck was effective at helping patients sleep, it also had dangerous side effects including daytime drowsiness and suicidal thinking, a Food and Drug Administration advisory committee warned.

    Comment?

  10. FDA staff says Merck's sleep drug effective, questions dosageRead the original story

    Monday May 20 | Reuters

    Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels.

    Comment?

  11. Merck Experimental Sleeping Pill, Suvorexant, Effective Says FDARead the original story

    Monday May 20 | Medical Daily

    An advisory committee within the U.S. Food and Drug Administration has said that Merck's new drug for insomnia and sleep maintenance, named Suvorexant , is quite effective in helping people get to sleep and maintain sleep patterns.

    Comment?

  12. FDA review says Merck's insomnia pill could have troubling side effectsRead the original story w/Photo

    Monday May 20 | The Jersey Journal

    Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

    Comment?

  13. UPDATE 2-FDA staff says Merck's sleep drug effective, questions dosageRead the original story

    Monday May 20 | Reuters

    The reviewers posted their comments on the FDA's website on Monday, two days ahead of a meeting of outside medical experts which will advise the agency on whether or not it should approve the drug.

    Comment?

  14. When Breath Saves LifeRead the original story

    Thursday May 16 | Psychology Today

    "They're all yours," says the psychiatrist. In front of me, a group of 15 young men.

    Comment?

  15. FDA OKs changes to drug labels for zolpidem medsRead the original story

    Friday May 17 | Nurse.com

    The FDA has approved label changes specifying new dosing recommendations for widely prescribed sleep medications that contain zolpidem.

    Comment?

  16. Ambien to lower doses for women, possibly menRead the original story w/Photo

    Wednesday May 15 | ABC7 Chicago

    The FDA announced new, lower dose labeling for Ambien, which is also known as zolpidem.

    Comment?

  17. Yoga may help ease high blood pressureRead the original story w/Photo

    Thursday May 16 | WJRT

    People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.

    Comment?

  18. New drug may help immune system fight cancerRead the original story w/Photo

    Thursday May 16 | WJRT

    People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.

    Comment?

  19. Fitness in middle age may help shield men from cancer laterRead the original story w/Photo

    Thursday May 16 | WJRT

    People who follow the ancient practice of yoga may be getting an added health boost, with a new study suggesting it can fight high blood pressure -- also known as hypertension.

    Comment?

  20. FDA: Lower Ambien's dose to prevent drowsy drivingRead the original story w/Photo

    Thursday May 16 | WJRT

    WEDNESDAY, May 15 -- The U.S. Food and Drug Administration has approved new, lower-dose labeling for the popular sleep drug Ambien in an effort to cut down on daytime drowsiness that could be a hazard while performing certain tasks such as driving.

    Comment?